Orgalutran Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Thai FDA Category Presentation/Packing Local Product Insert

Concise Prescribing Info

Contents

Ganirelix

Indications/Uses

Prevention of premature LH surges in women undergoing controlled ovarian hyperstimulation (COH) for assisted reproduction techniques (ART).

Click to view Orgalutran detailed prescribing information

Dosage/Direction for Use

SC 0.25 mg once daily, starting on day 6 of FSH administration. COH w/ FSH May start at day 2 or 3 of menses. High responders Starting treatment on day 5 may prevent early LH rise.

Click to view Orgalutran detailed prescribing information

Overdosage

View Orgalutran overdosage for action to be taken in the event of an overdose.

Contraindications

Hypersensitivity to ganirelix, gonadotrophin-releasing hormone (GnRH) or any other GnRH analogue. Moderate or severe renal or hepatic impairment. Pregnancy & lactation.

Click to view Orgalutran detailed prescribing information

Special Precautions

Discontinue use if hypersensitivity reaction is suspected. Not advised in women w/ severe allergic conditions. Anaphylaxis (including anaphylactic shock), angioedema, & urticaria. Ovarian hyperstimulation syndrome (OHSS) during or following ovarian stimulation; symptomatically treat w/ rest, IV infusion of electrolyte soln or colloids & heparin. Increased incidence of ectopic pregnancies in infertile women w/ tubal abnormalities undergoing assisted reproduction particularly IVF; congenital malformations after ART. Women weighing <50 kg or >90 kg.

Click to view Orgalutran detailed prescribing information

Use In Pregnancy & Lactation

Click to view Orgalutran detailed prescribing information

Adverse Reactions

Local inj site skin reactions (predominantly redness w/ or w/o swelling), malaise; headache; nausea. Pelvic pain, abdominal distension, OHSS, ectopic pregnancy & spontaneous abortion.

Click to view Orgalutran detailed prescribing information

Caution For Usage

For caution against possible variation of physical aspect of medicine... Click to view Orgalutran detailed prescribing information

Storage

View Orgalutran storage conditions for details to ensure optimal shelf-life.

Description

View Orgalutran description for details of the chemical structure and excipients (inactive components).

Action

View Orgalutran mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Trophic Hormones & Related Synthetic Drugs

ATC Classification

H01CC01 - ganirelix ; Belongs to the class of anti-gonadotropin-releasing hormones. Used in hypothalamic hormone preparations.

Thai FDA Category

Presentation/Packing

Form

Orgalutran soln for inj 0.25 mg/0.5 mL

Packing/Price

1's;5 × 1's

Orgalutran

ganirelix

Manufacturer:

Organon

Distributor:

Zuellig Pharma